Citigroup’s NewAge, Inc. Common Stock (Delaware) NBEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-22,300
Closed -$59K 7727
2020
Q4
$59K Hold
22,300
﹤0.01% 5930
2020
Q3
$39K Sell
22,300
-4,000
-15% -$7.78K ﹤0.01% 5759
2020
Q2
$40K Sell
26,300
-7,600
-22% -$11.3K ﹤0.01% 6164
2020
Q1
$47K Sell
33,900
-10,100
-23% -$18.2K ﹤0.01% 6028
2019
Q4
$80K Buy
44,000
+4,400
+11% +$10.4K ﹤0.01% 5957
2019
Q3
$109K Buy
39,600
+9,100
+30% +$32.1K ﹤0.01% 5611
2019
Q2
$142K Buy
+30,500
New +$156K ﹤0.01% 5558

Other funds holding NBEV

Citigroup's NBEV Position: Q3 2022 in Review

Citigroup sold out of NewAge, Inc. Common Stock (Delaware) (NBEV) in Q3 2022, closing a stake of 10,267 shares — an estimated $2K sold.

Citigroup first reported a position in NBEV in Q1 2019 and held it in 14 quarters. The position peaked at $399K in Q1 2019. 12 funds tracked by Wall St. Rank hold NBEV as of Q3 2022.

  • Citigroup reported no remaining NewAge, Inc. Common Stock (Delaware) position as of Q3 2022 after selling out during the quarter.
  • Citigroup sold 10,267 NewAge, Inc. Common Stock (Delaware) shares in Q3 2022, an estimated $2K.
  • Citigroup first reported a position in NewAge, Inc. Common Stock (Delaware) in Q1 2019 and held it in 14 quarters.
  • Citigroup's NewAge, Inc. Common Stock (Delaware) position peaked at $399K in Q1 2019.
  • 12 funds tracked by Wall St. Rank held NewAge, Inc. Common Stock (Delaware) as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.